Compile Data Set for Download or QSAR
maximum 50k data
Found 352 with Last Name = 'sugiyama' and Initial = 'h'
TargetHistone acetyltransferase p300(Homo sapiens (Human))
Kyoto University

Curated by ChEMBL
LigandPNGBDBM50456444(CHEMBL3734823)
Affinity DataKi:  400nMAssay Description:Inhibition of VMA intein chitin binding domain-fused p300 HAT domain (1287 to 1652 residues) (unknown origin) expressed in Escherichia coli BL21(RIL)...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364189(CHEMBL1951813)
Affinity DataIC50:  0.0170nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364190(CHEMBL1951810)
Affinity DataIC50:  0.0200nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364190(CHEMBL1951810)
Affinity DataIC50:  0.0200nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM47085(US8592454, 71b)
Affinity DataIC50:  0.0270nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM106978(US8592454, 176)
Affinity DataIC50:  0.0290nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM106983(US8592454, 420)
Affinity DataIC50:  0.0300nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM106974(US8592454, 25)
Affinity DataIC50:  0.0310nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM106979(US8592454, 192)
Affinity DataIC50:  0.0320nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364202(CHEMBL1951626)
Affinity DataIC50:  0.0320nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364195(CHEMBL1951633)
Affinity DataIC50:  0.0350nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM106982(US8592454, 378)
Affinity DataIC50:  0.0390nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364197(CHEMBL1951631)
Affinity DataIC50:  0.0430nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364192(CHEMBL1951811)
Affinity DataIC50:  0.0460nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364198(CHEMBL1951630)
Affinity DataIC50:  0.0470nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364196(CHEMBL1951632)
Affinity DataIC50:  0.0480nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM106980(US8592454, 233)
Affinity DataIC50:  0.0490nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364199(CHEMBL1951629)
Affinity DataIC50:  0.0520nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364201(CHEMBL1951627)
Affinity DataIC50:  0.0640nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM106981(US8592454, 308)
Affinity DataIC50:  0.0700nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364194(CHEMBL1951634)
Affinity DataIC50:  0.0730nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM106977(US8592454, 104)
Affinity DataIC50:  0.0730nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM106976(US8592454, 66)
Affinity DataIC50:  0.0750nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM97478(US8470816, 91)
Affinity DataIC50:  0.0920nMpH: 7.4Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364207(CHEMBL1951621)
Affinity DataIC50:  0.0980nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364193(CHEMBL1951635)
Affinity DataIC50:  0.110nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM106973(US8592454, 4)
Affinity DataIC50:  0.110nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364203(CHEMBL1951625)
Affinity DataIC50:  0.140nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364205(CHEMBL1951623)
Affinity DataIC50:  0.170nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMatrix metalloproteinase-9(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50062351((R)-N*4*-Hydroxy-N*1*-[(S)-2-(1H-indol-3-yl)-1-met...)
Affinity DataIC50:  0.177nMAssay Description:Inhibition of human MMP-9 by fluorometric assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364204(CHEMBL1951624)
Affinity DataIC50:  0.180nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364188(CHEMBL1951814)
Affinity DataIC50:  0.200nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSubstance-P receptor(Homo sapiens (Human))
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50364200(CHEMBL1951628)
Affinity DataIC50:  0.210nMAssay Description:Displacement of [125I]BH-SP from tachykinin NK1 receptor in human IM9 cells after 30 mins by scintillation countingMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDNA gyrase subunit A/B(Escherichia coli (strain K12))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554205(CHEMBL4757242)
Affinity DataIC50:  0.210nMAssay Description:Inhibition of Escherichia coli DNA gyrase by measuring supercoiling activity incubated for 60 mins by fluorescence based assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97485(US8470816, 458)
Affinity DataIC50:  0.220nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97486(US8470816, 464)
Affinity DataIC50:  0.220nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97489(US8470816, 632)
Affinity DataIC50:  0.220nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97481(US8470816, 265)
Affinity DataIC50:  0.230nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97490(US8470816, 633)
Affinity DataIC50:  0.240nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97483(US8470816, 292)
Affinity DataIC50:  0.25nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDNA gyrase subunit A/B(Escherichia coli (strain K12))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554208(CHEMBL4784687)
Affinity DataIC50:  0.260nMAssay Description:Inhibition of Escherichia coli DNA gyrase by measuring supercoiling activity incubated for 60 mins by fluorescence based assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetDNA gyrase subunit A/B(Escherichia coli (strain K12))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554207(CHEMBL4758336)
Affinity DataIC50:  0.290nMAssay Description:Inhibition of Escherichia coli DNA gyrase by measuring supercoiling activity incubated for 60 mins by fluorescence based assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97479(US8470816, 251a)
Affinity DataIC50:  0.310nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetDNA gyrase subunit A/B(Escherichia coli (strain K12))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554204(CHEMBL4743844)
Affinity DataIC50:  0.310nMAssay Description:Inhibition of Escherichia coli DNA gyrase by measuring supercoiling activity incubated for 60 mins by fluorescence based assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97487(US8470816, 623)
Affinity DataIC50:  0.310nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97491(US8470816, 635)
Affinity DataIC50:  0.360nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetDNA gyrase subunit A/B(Escherichia coli (strain K12))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554200(CHEMBL4764566)
Affinity DataIC50:  0.360nMAssay Description:Inhibition of Escherichia coli DNA gyrase by measuring supercoiling activity incubated for 60 mins by fluorescence based assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sidPDB
TargetSubstance-K receptor(Homo sapiens (Human))
Takeda Pharmaceutical

US Patent
LigandPNGBDBM97482(US8470816, 268)
Affinity DataIC50:  0.420nMpH: 7.5Assay Description:Radioligan receptor binding inhibitory activity using membrane fraction of CHO cell expressing human NK receptors.More data for this Ligand-Target Pair
In DepthDetails US Patent
Target72 kDa type IV collagenase(Homo sapiens (Human))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50062351((R)-N*4*-Hydroxy-N*1*-[(S)-2-(1H-indol-3-yl)-1-met...)
Affinity DataIC50:  0.422nMAssay Description:Inhibition of human MMP-2 by fluorometric assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDNA gyrase subunit A/B(Escherichia coli (strain K12))
Taisho Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50554197(CHEMBL4776319)
Affinity DataIC50:  0.430nMAssay Description:Inhibition of Escherichia coli DNA gyrase by measuring supercoiling activity incubated for 60 mins by fluorescence based assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 352 total ) | Next | Last >>
Jump to: